Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions.
$0.90+0.48%
报价 2026-11-13
市值
$91.6M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -82.8%
$0.81$5.23
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Instruments & Supplies| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NYXHNyxoah S.A. | $91.6M | +0.5% | – | 51.3% | – | – | – | |
| UTMDUtah Medical Products, Inc. | $205M | -2.3% | – | 52.9% | 19.1x | 7.4x | 27.0x | |
| NNNNAnbio Biotechnology Class A Ordinary Shares | $167.7M | +0.5% | – | 86.1% | 19.7x | 24.6x | – | |
| KRMDKORU Medical Systems, Inc. | $160.5M | +0.3% | +18.8% | 63.2% | – | – | – | |
| STXSStereotaxis, Inc. | $84.5M | -0.8% | +20.1% | 55.6% | – | – | – | |
| MBOTMicrobot Medical Inc. | $65.7M | -5.0% | +4900.0% | -9.5% | – | – | – | |
| POCIPrecision Optics Corporation, Inc. | $57.4M | +4.6% | – | 9.7% | – | – | – | |
| DXRDaxor Corporation | $49.5M | +0.2% | – | -57.5% | 5.8x | 5.6x | – | |
| HBIOHarvard Bioscience, Inc. | $42.9M | +1.9% | +3.1% | 53% | – | 11.2x | – | |
| 同行中位数 | – | – | +19.5% | 53% | 19.1x | 9.3x | 27.0x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
报告货币 EUR(非美元)暂无季度数据(首次研究运行后填充)。
研究材料
电话会纪要摘要
暂无纪要摘要。